SCHEMBL18334098

SCHEMBL18334098

C=C1C(=O)O[C@@H]2[C@@H]3[C@@H](CC[C@@]3(C)O)[C@](C)(O)CC[C@@H]12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 5/20 0.51
NLRP3 Q96P20 2/20 0.51
UBE2D3 P61077 2/20 0.43
ALDH1A1 P00352 4/20 0.41
LMNA P02545 3/20 0.41
TP53 P04637 3/20 0.41
CYP3A4 P08684 3/20 0.41
NFKB1 P19838 2/20 0.41
CYP1A2 P05177 2/20 0.41
STAT6 P42226 2/20 0.41
MAPT P10636 2/20 0.41
PTGS2 P35354 2/20 0.41
CASP1 P29466 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
CYP2D6 P10635 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
THPO P40225 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17147744 0.87 PKM (0.46) PKMNLRP3UBE2D3ALDH1A1LMNA
SCHEMBL18334095 0.87 PKM (0.46) PKMNLRP3UBE2D3ALDH1A1LMNA
SCHEMBL17147754 0.83 PKM (0.55) PKMNLRP3UBE2D3ALDH1A1LMNA
SCHEMBL17147746 0.83 PKM (0.55) PKMNLRP3UBE2D3ALDH1A1LMNA
SCHEMBL26313818 0.83 PKM (0.42) PKMNLRP3UBE2D3ALDH1A1LMNA
SCHEMBL30463131 0.81 PKM (0.47) PKMNLRP3UBE2D3ALDH1A1LMNA
SCHEMBL21527011 0.80 PKM (0.48) PKMNLRP3UBE2D3ALDH1A1LMNA
SCHEMBL29660633 0.79 PKM (0.39) PKMNLRP3UBE2D3ALDH1A1MAPT
SCHEMBL18334077 0.75 PKM (0.40) PKMNLRP3UBE2D3ALDH1A1LMNA
SCHEMBL29935069 0.74 PKM (0.48) PKMNLRP3UBE2D3ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10463644-B2 Uses of sesquiterpene lactone compounds and their derivatives in drugs preparation ACCENDATECH (CN) 2019-11-05 US disclosed
US-20160367525-A1 USES OF SESQUITERPENE LACTONE COMPOUNDS AND THEIR DERIVATIVES IN DRUGS PREPARATION ACCENDATECH (CN) 2016-12-22 US disclosed
US-20160367525-A1 USES OF SESQUITERPENE LACTONE COMPOUNDS AND THEIR DERIVATIVES IN DRUGS PREPARATION ACCENDATECH (CN) 2016-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10463644-B2 Uses of sesquiterpene lactone compounds and their derivatives in drugs preparation MCL1, TNF, LSS PKM 3846/4885NLRP3 745/4885UBE2D3 1874/4885
US-20160367525-A1 USES OF SESQUITERPENE LACTONE COMPOUNDS AND THEIR DERIVATIVES IN DRUGS PREPARATION MCL1, TNF, LSS PKM 3846/4885NLRP3 745/4885UBE2D3 1874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.